Evidence map›Paper›PMID 25850026›Full record

GuidelineThe Journal of clinical endocrinology and metabolism2015

Measuring Estrogen Exposure and Metabolism: Workshop Recommendations on Clinical Issues.

L M Demers, S E Hankinson, S Haymond, T Key, W Rosner, R J Santen, F Z Stanczyk, H W Vesper, R G Ziegler, Endocrine Society and 2 more

Abstract readConsensus StatementPractice Guideline
In one paragraph

Guideline in The Journal of clinical endocrinology and metabolism, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Circulating Estrogen Metabolites and Risk of Breast Cancer among Postmenopausal Women in the Nurses' Health Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Estrogenic Activity and Risk of Invasive Breast Cancer Among Postmenopausal Women in the Nurses' Health Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

L M DemersDepartments of Pathology and Medicine (L.M.D.), Pennsylvania State University School of Medicine, Hershey, Pennsylvania 17003; Division of Biostatistics and Epidemiology (S.E.H.), University of Massachusetts, Amherst, Massachusetts 01003; Ann and Robert H. Lurie Children's Hospital of Chicago (S.H.), Chicago, Illinois 60611; Nuffield Department of Population Health (T.K.), University of Oxford, Oxford OX3 7LF, United Kingdom; Department of Medicine (W.R.), Columbia University, College of Physicians and Surgeons, New York, New York 10032; Division of Endocrinology and Metabolism (R.J.S.), University of Virginia Health Sciences System, Charlottesville, Virginia 22903; Departments of Obstetrics/Gynecology and Preventive Medicine (F.Z.S.), University of Southern California Keck School of Medicine, Los Angeles, California 90033; Division of Laboratory Sciences (H.W.V.), Centers for Disease Control and Prevention, Atlanta, Georgia 30333; and Division of Cancer Epidemiology and Genetics (R.G.Z.), National Cancer Institute, Bethesda, Maryland 20892.
S E HankinsonDepartments of Pathology and Medicine (L.M.D.), Pennsylvania State University School of Medicine, Hershey, Pennsylvania 17003; Division of Biostatistics and Epidemiology (S.E.H.), University of Massachusetts, Amherst, Massachusetts 01003; Ann and Robert H. Lurie Children's Hospital of Chicago (S.H.), Chicago, Illinois 60611; Nuffield Department of Population Health (T.K.), University of Oxford, Oxford OX3 7LF, United Kingdom; Department of Medicine (W.R.), Columbia University, College of Physicians and Surgeons, New York, New York 10032; Division of Endocrinology and Metabolism (R.J.S.), University of Virginia Health Sciences System, Charlottesville, Virginia 22903; Departments of Obstetrics/Gynecology and Preventive Medicine (F.Z.S.), University of Southern California Keck School of Medicine, Los Angeles, California 90033; Division of Laboratory Sciences (H.W.V.), Centers for Disease Control and Prevention, Atlanta, Georgia 30333; and Division of Cancer Epidemiology and Genetics (R.G.Z.), National Cancer Institute, Bethesda, Maryland 20892.
S HaymondDepartments of Pathology and Medicine (L.M.D.), Pennsylvania State University School of Medicine, Hershey, Pennsylvania 17003; Division of Biostatistics and Epidemiology (S.E.H.), University of Massachusetts, Amherst, Massachusetts 01003; Ann and Robert H. Lurie Children's Hospital of Chicago (S.H.), Chicago, Illinois 60611; Nuffield Department of Population Health (T.K.), University of Oxford, Oxford OX3 7LF, United Kingdom; Department of Medicine (W.R.), Columbia University, College of Physicians and Surgeons, New York, New York 10032; Division of Endocrinology and Metabolism (R.J.S.), University of Virginia Health Sciences System, Charlottesville, Virginia 22903; Departments of Obstetrics/Gynecology and Preventive Medicine (F.Z.S.), University of Southern California Keck School of Medicine, Los Angeles, California 90033; Division of Laboratory Sciences (H.W.V.), Centers for Disease Control and Prevention, Atlanta, Georgia 30333; and Division of Cancer Epidemiology and Genetics (R.G.Z.), National Cancer Institute, Bethesda, Maryland 20892.
T KeyDepartments of Pathology and Medicine (L.M.D.), Pennsylvania State University School of Medicine, Hershey, Pennsylvania 17003; Division of Biostatistics and Epidemiology (S.E.H.), University of Massachusetts, Amherst, Massachusetts 01003; Ann and Robert H. Lurie Children's Hospital of Chicago (S.H.), Chicago, Illinois 60611; Nuffield Department of Population Health (T.K.), University of Oxford, Oxford OX3 7LF, United Kingdom; Department of Medicine (W.R.), Columbia University, College of Physicians and Surgeons, New York, New York 10032; Division of Endocrinology and Metabolism (R.J.S.), University of Virginia Health Sciences System, Charlottesville, Virginia 22903; Departments of Obstetrics/Gynecology and Preventive Medicine (F.Z.S.), University of Southern California Keck School of Medicine, Los Angeles, California 90033; Division of Laboratory Sciences (H.W.V.), Centers for Disease Control and Prevention, Atlanta, Georgia 30333; and Division of Cancer Epidemiology and Genetics (R.G.Z.), National Cancer Institute, Bethesda, Maryland 20892.
W RosnerDepartments of Pathology and Medicine (L.M.D.), Pennsylvania State University School of Medicine, Hershey, Pennsylvania 17003; Division of Biostatistics and Epidemiology (S.E.H.), University of Massachusetts, Amherst, Massachusetts 01003; Ann and Robert H. Lurie Children's Hospital of Chicago (S.H.), Chicago, Illinois 60611; Nuffield Department of Population Health (T.K.), University of Oxford, Oxford OX3 7LF, United Kingdom; Department of Medicine (W.R.), Columbia University, College of Physicians and Surgeons, New York, New York 10032; Division of Endocrinology and Metabolism (R.J.S.), University of Virginia Health Sciences System, Charlottesville, Virginia 22903; Departments of Obstetrics/Gynecology and Preventive Medicine (F.Z.S.), University of Southern California Keck School of Medicine, Los Angeles, California 90033; Division of Laboratory Sciences (H.W.V.), Centers for Disease Control and Prevention, Atlanta, Georgia 30333; and Division of Cancer Epidemiology and Genetics (R.G.Z.), National Cancer Institute, Bethesda, Maryland 20892.
R J SantenDepartments of Pathology and Medicine (L.M.D.), Pennsylvania State University School of Medicine, Hershey, Pennsylvania 17003; Division of Biostatistics and Epidemiology (S.E.H.), University of Massachusetts, Amherst, Massachusetts 01003; Ann and Robert H. Lurie Children's Hospital of Chicago (S.H.), Chicago, Illinois 60611; Nuffield Department of Population Health (T.K.), University of Oxford, Oxford OX3 7LF, United Kingdom; Department of Medicine (W.R.), Columbia University, College of Physicians and Surgeons, New York, New York 10032; Division of Endocrinology and Metabolism (R.J.S.), University of Virginia Health Sciences System, Charlottesville, Virginia 22903; Departments of Obstetrics/Gynecology and Preventive Medicine (F.Z.S.), University of Southern California Keck School of Medicine, Los Angeles, California 90033; Division of Laboratory Sciences (H.W.V.), Centers for Disease Control and Prevention, Atlanta, Georgia 30333; and Division of Cancer Epidemiology and Genetics (R.G.Z.), National Cancer Institute, Bethesda, Maryland 20892.
F Z StanczykDepartments of Pathology and Medicine (L.M.D.), Pennsylvania State University School of Medicine, Hershey, Pennsylvania 17003; Division of Biostatistics and Epidemiology (S.E.H.), University of Massachusetts, Amherst, Massachusetts 01003; Ann and Robert H. Lurie Children's Hospital of Chicago (S.H.), Chicago, Illinois 60611; Nuffield Department of Population Health (T.K.), University of Oxford, Oxford OX3 7LF, United Kingdom; Department of Medicine (W.R.), Columbia University, College of Physicians and Surgeons, New York, New York 10032; Division of Endocrinology and Metabolism (R.J.S.), University of Virginia Health Sciences System, Charlottesville, Virginia 22903; Departments of Obstetrics/Gynecology and Preventive Medicine (F.Z.S.), University of Southern California Keck School of Medicine, Los Angeles, California 90033; Division of Laboratory Sciences (H.W.V.), Centers for Disease Control and Prevention, Atlanta, Georgia 30333; and Division of Cancer Epidemiology and Genetics (R.G.Z.), National Cancer Institute, Bethesda, Maryland 20892.
H W VesperDepartments of Pathology and Medicine (L.M.D.), Pennsylvania State University School of Medicine, Hershey, Pennsylvania 17003; Division of Biostatistics and Epidemiology (S.E.H.), University of Massachusetts, Amherst, Massachusetts 01003; Ann and Robert H. Lurie Children's Hospital of Chicago (S.H.), Chicago, Illinois 60611; Nuffield Department of Population Health (T.K.), University of Oxford, Oxford OX3 7LF, United Kingdom; Department of Medicine (W.R.), Columbia University, College of Physicians and Surgeons, New York, New York 10032; Division of Endocrinology and Metabolism (R.J.S.), University of Virginia Health Sciences System, Charlottesville, Virginia 22903; Departments of Obstetrics/Gynecology and Preventive Medicine (F.Z.S.), University of Southern California Keck School of Medicine, Los Angeles, California 90033; Division of Laboratory Sciences (H.W.V.), Centers for Disease Control and Prevention, Atlanta, Georgia 30333; and Division of Cancer Epidemiology and Genetics (R.G.Z.), National Cancer Institute, Bethesda, Maryland 20892.
R G ZieglerDepartments of Pathology and Medicine (L.M.D.), Pennsylvania State University School of Medicine, Hershey, Pennsylvania 17003; Division of Biostatistics and Epidemiology (S.E.H.), University of Massachusetts, Amherst, Massachusetts 01003; Ann and Robert H. Lurie Children's Hospital of Chicago (S.H.), Chicago, Illinois 60611; Nuffield Department of Population Health (T.K.), University of Oxford, Oxford OX3 7LF, United Kingdom; Department of Medicine (W.R.), Columbia University, College of Physicians and Surgeons, New York, New York 10032; Division of Endocrinology and Metabolism (R.J.S.), University of Virginia Health Sciences System, Charlottesville, Virginia 22903; Departments of Obstetrics/Gynecology and Preventive Medicine (F.Z.S.), University of Southern California Keck School of Medicine, Los Angeles, California 90033; Division of Laboratory Sciences (H.W.V.), Centers for Disease Control and Prevention, Atlanta, Georgia 30333; and Division of Cancer Epidemiology and Genetics (R.G.Z.), National Cancer Institute, Bethesda, Maryland 20892.
Endocrine Society
PATH (Partnership for Accurate Testing of Hormones)
AACC (American Association for Clinical Chemistry)

Funding

Cancer Research UK 16491Intramural NIH HHS
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Congresses as TopicEnvironmental ExposureEstrogensHumansImmunoassayReference StandardsReproducibility of ResultsSpectrum AnalysisValidation Studies as TopicEstrogens

Identifiers

PMID25850026
PMCPMC5393513

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.